ArticleMethods in molecular biology (Clifton, N.J.)2026
Identification of Clinically Relevant Genes Using Machine Learning Techniques.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Machine learning (ML) has demonstrated great potential and considerable effectiveness in big data analysis. It is capable of extracting novel features, including indicators or biomarkers in biology, that are unachievable with previously existing methodologies. Biomarkers are used to measure and evaluate biological and pathological processes, or pharmacological responses to assess patient status. In clinical settings, biomarkers enable the prediction and detection of many aspects, such as prognosis, drug response, and tumor recurrence. Stratification using RNA expression is the gold standard for patient prognosis in cancer. In this chapter, we describe a practical guide for identifying clinically relevant biomarkers using ML. First, integrated multi-omics data are used as input data for the analysis. Then, an autoencoder is used for dimension reduction, and a bottleneck feature space of 100 dimensions is used to extract clinically relevant features. Finally, we identify biomarkers related to the outcomes from the transcriptome data.
Indexed as
Identifiers
42681525What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.